Latest "Alimera Sciences Present 29th Annual ROTH Conference" News Stories

21:42 EST 9th December 2018 | BioPortfolio

Here are the most relevant search results for "Alimera Sciences Present 29th Annual ROTH Conference" found in our extensive news archives from over 250 global news sources.

More Information about Alimera Sciences Present 29th Annual ROTH Conference on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Alimera Sciences Present 29th Annual ROTH Conference for you to read. Along with our medical data and news we also list Alimera Sciences Present 29th Annual ROTH Conference Clinical Trials, which are updated daily. BioPortfolio also has a large database of Alimera Sciences Present 29th Annual ROTH Conference Companies for you to search.

Showing "Alimera Sciences Present 29th Annual ROTH Conference" News Articles 1–25 of 14,000+

Sunday 9th December 2018

Final agenda for INVEST 2019 published as MedCity invites speaker applications

The agenda for INVEST 2019 has been finalized as we gear up for our annual flagship conference in Chicago, April 23-24 and invite speakers and startups to apply.

Saturday 8th December 2018

Generon Presented Positive Phase III Results From a Double-Blind, Placebo Controlled-Clinical Trial of F-627 in Women with Breast Cancer Receiving Myelotoxic Chemotherapy

F-627 significantly reduced the duration and incidence of severe, and febrile, neutropenia Generon BioMed Holding Ltd. (Generon), announced today at the annual San Antonio Breast Cancer Symposium (SABCS), positive results from a placebo-controlled trial with F-627, a recombinant human Granulocyte Colony Stimulating Factor (rhG-CSF) protein, designed us...

Sydney Masciarelli and Cole Hocker Capture First Place Titles at the 40th Annual Foot Locker ...

SAN DIEGO, Dec. 8, 2018 /PRNewswire/ -- Sydney Masciarelli of Northbridge, Mass. and Cole Hocker of Indianapolis captured first place titles at the 40th annual Read more...

Alimera Sciences Inc ALIM Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryAlimera Sciences Inc Alimera is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company's products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabetic macular edema DME in patients who have been previously treated with corticosteroids and did not show...

Garland Honored For Its Spirit Week Tradition of Supporting Non-Profit Organizations

CLEVELAND (PRWEB) December 07, 2018 Garland was recently honored with a Medical Mutual Pillar Award for Community Service for its annual tradition of supporting non-profit organizations through fun, creative and thoughtful fundraising. Garland’s philanthropic initiative called Spirit Week beg...

Amyotrophic Lateral Sclerosis: Opportunity Analysis and Forecast to 2027 [Report Updated: 18072018] Prices from USD $9346

Amyotrophic Lateral Sclerosis: Opportunity Analysis and Forecast to 2027SummaryAmyotrophic Lateral Sclerosis ALS is a motor neuron degenerative disease which affects both upper motor neurons UMN and lower motor neurons LMN. It is a progressive disease, with patients becoming increasingly dependent on carers and physicians as time from onset increases, and ultimately, it is fatal. ALS can be split ...

Friday 7th December 2018

Quidel to Hold BNP Supply Agreement Update Conference Call on December 10, 2018

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will hold a conference call on December 10, 2018 to discuss the San Diego Superior Court’s ruling related to Quidel’s BNP Supply Agreement with Beckman. Douglas Bryant, president and chief execut...

GRACE & Living Yoga Therapy Present: Living Through Cancer and Managing Anger

Raquel Jex Forsgren, Yoga Therapist, C-IAYT

CellCube Energy Storage Announces the Filing of Audited Annual Financials

TORONTO, December 7, 2018 /PRNewswire/ -- CellCube Energy Storage Systems Inc. ("CellCube" or the "Company") (CSE: CUBE) (OTCQB: CECBF) (Frankfurt 01X, WKN A2JMGP) announces that Read more...

Help GRACE Help Others

Join us in our annual, end of year appeal for GRACE. Won't you help? GRACE has gone through some great changes this year, and more great things are coming.  GRACE isn't about runs or galas, we aren't like other nonprofit organizations.  GRACE is about content, and GRACE is about you.  Please help us help others, and give today!  Donate Here Featured Image: 

Los Angeles Cardiologist Ernst von Schwarz, MD Advises Women To Be Aware Of Heart Disease Risks

“The issue of women and heart disease is serious, as many women go undiagnosed, are misdiagnosed or receive the wrong treatments,” says Dr. von Schwarz. LOS ANGELES (PRWEB) December 07, 2018 Cardiologist Ernst von Schwarz, MD says that women can experience unique warning signs of heart disease which can be mistaken for other issues or ignored completely by their doctors. “This can be especi...

Intra-aortic balloon pumps most successful within hour of cardiogenic shock

Patients who present to the hospital with cardiogenic shock (CS) and are treated with an intra-aortic balloon pump (IABP) are more likely to survive if the device is implanted within an hour of CS onset, according to research published in the American Journal of Cardiology Dec. 4.

Metered Dose Inhaler (MDI) Technology: 2-Day Seminar (London, United Kingdom – February 20-21, 2019) –

DUBLIN–(BUSINESS WIRE)–The “Metered Dose Inhaler (MDI) Technology” conference has been added to’s offering. A comprehensive overview of MDIs including development, manufacture, regulation and market potential This interactive seminar will provide a comprehensive overview of metered-dose inhaler technology. It will … Continue reading →...

Common Technical Document: 2-Day Course (London, United Kingdom – December 4-5, 2019) –

DUBLIN–(BUSINESS WIRE)–The “Common Technical Document” conference has been added to’s offering. This two-day course will provide you with a clear understanding of the regulatory and technical requirements for CMC management of your full and generic application in major markets … Continue reading →

SABCS18 An in-depth review of key breast cancer trials

San Antonio – As the Fall conference season is rapidly drawing to a close, it’s time to highlight some key findings…

Quidel Comments on California Court Ruling

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that the San Diego Superior Court (the “Court”) stated that it intends to enter an order granting Beckman’s motion for summary adjudication relating to the agreement for t...

American Society of Hematology, Dec. 1-4

The 60th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec. 1 to 4 in San Diego and attracted approximately 22,000 participants from around the world, including...

Harvest Health & Recreation, Inc. to hold Conference Call to Discuss Q3 2018 Results and Performance Outlook

Harvest Health & Recreation, Inc. (HARV: CSE) will hold its Third Quarter 2018 earnings conference call on: Tuesday, December 11, 20188:30 AM (Eastern Time) Participating on the call to review Harvest Health & Recreation’s Third Quarter 2018 financial and operating results will be Jason Vedadi, Executive Chairman, Steve White, C...

The combined analysis of carfilzomib trials

Prof Maria-Victoria Mateos speaks to ecancer at the ASH 2018 Annual Meeting about the efficacy and safety results of carfilzomib and dexmethasone in lenalidomide exposed and refractory multiple myeloma patients. She outlines the rationale for the...

UK government, industry leaders invest billions in research, AI for early disease detection

The UK government and life sciences industry leaders are investing more than £1 billion to support healthcare innovation and research aimed at using AI for early disease detection.

Study: Echocardiography may reveal keys to ‘obesity paradox’ in heart failure

A study presented Dec. 6 at the EuroEcho-Imaging 2018 conference in Milan adds to the debate over the "obesity paradox," finding that acute heart failure patients with a body mass index (BMI) of 23 or higher had better survival over nearly three years of follow-up than those with a BMI below that threshold.

Magellan Health, Inc. (MGLN) 2019 Financial Guidance Conference (Transcript)

Neptune Wellness Solutions moves in to the Cannabis wellness space

Neptune Wellness Solutions (TSX: NEPT-NASDAQ: NEPT) CEO Jim Hamilton joined Steve Darling from Proactive Investors in Los Angeles at the LD Micro conference to talk about his company moving in to the Cannabis wellness space. Hamilton gave a timeline for completion of their license from Health Canada.  

Complaints against doctors fell by 8% in 2017

Complaints about doctors to the General Medical Council are falling and more cases are being resolved without a full investigation, the latest annual report from the regulator shows.1Numbers of...

NEX China Helping Enterprises Explore New Directions as Plant Extract Market Rises Rapidly

SHANGHAI, Dec. 7, 2018 /PRNewswire/ -- NEX China, co-organized by UBM Sinoexpo and a supporter of the China's extract industry for 10 years since its founding, will take place again in Hall E4-E5 of Shanghai New International Expo Centre (SNIEC) on June 18-20, 2019. In response to the flourishing of the international natural extract industry and resource advantages of China in the animal and ...

Quick Search


News Quicklinks